Cell And Gene Therapy Manufacturing

  1. Major Trends Impacting Allogeneic Cell Therapies For Oncology 5/6/2024

    We kicked off this Cell & Gene Live, Unlocking the Future of Allogeneic Cell Therapy for Oncology by discussing the major trends impacting allogeneic cell therapies for oncology.

  2. Ultralow Particulate Bottles And Carboys: Where Being Particular About Particulates Is Critical 5/27/2025

    Optimize your operations with ready-to-use, meticulously prepared containers. Learn how our commitment to cleanliness reduces risks and supports your most critical requirements.

  3. Optimization Of Anion Exchange Purification For The Large-Scale Production Of Plasmid DNA 11/4/2025

    In this webinar, we discuss pDNA purification, including how to identify optimal conditions for various chromatography media and optimize recovery and impurity removal.

  4. Ensuring Quality, Driving Customer Confidence 7/15/2025

    How does quality assurance help drive scientific progress? A 30-year veteran shares her story of supporting customer needs and the development of groundbreaking new therapeutics.

  5. BPI Interviews Purification And Pharma Analytics Leader 6/9/2025

    Jean Luo, VP of Purification and Pharma Analytics, discusses innovations in bioprocessing, including the development of dPCR assays, lentiviral titer systems, chromatography resins, and supply chain.

  6. Best Practices For Effective Donor Management 5/6/2024

    Starting with high quality donor material is critical for allogeneic cell therapy drug manufacturing, and this requires laying the groundwork for a high-touch, end-to-end donor pool management strategy.

  7. Take The Lead With The Gibco CHOvantage™ GS Cell Line Development Kit 3/13/2026

    See how this kit accelerates clone development to 14 weeks with ≥7 g/L protein titers while reducing costs through royalty-free commercial licensing for therapeutic applications.

  8. Manufacturing Considerations For Viral & Non-Viral Platform Selection 6/24/2025

    In this webinar, a panel of experts spanning the lentiviral vector, exosome and oncolytic virus fields will discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies.

  9. Accelerating Process Scale-Up From Benchtop To Commercialization- From Controller To Software 11/4/2025

    Discover strategies for optimizing process control, refining media selection, and ensuring safety through rigorous contaminant detection to mitigate development risks.

  10. CTS DynaCellect Fluidics Demonstration 6/9/2025

    Streamline and customize your cell processing workflow with automated, precise control over fluid movement and transfer parameters.